ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/08/2023
Back to search
Official data from USPTO
LIPOFEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
03/08/2023
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
08/09/2005
Registration date
03/25/2008
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/12/2018
Last transaction
02/12/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/01/2007
First use in commerce
10/01/2007
Drawing code
4
Owner type
03
Owner location
Mississauga, Ontario, CA
Examiner
MAKHDOOM, SAIMA
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
Representatives
Cynthia Johnson Walden FISH & RICHARDSON P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cholesterol reducers; Pharmaceuticalslipid lowering agents
Publications
History of USPTO decisions and trademark events.
39 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/12/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/12/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/12/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/12/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
01/23/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/25/2017
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/22/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/14/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/14/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/10/2013
E815
TEAS SECTION 8 & 15 RECEIVED
04/18/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
03/25/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
02/15/2008
ALIE
ASSIGNED TO LIE
02/15/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/15/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/08/2008
IUAF
USE AMENDMENT FILED
12/06/2007
EISU
TEAS STATEMENT OF USE RECEIVED
12/06/2007
EX2G
SOU EXTENSION 2 GRANTED
09/18/2007
EXT2
SOU EXTENSION 2 FILED
08/09/2007
EEXT
SOU TEAS EXTENSION RECEIVED
08/09/2007
EX1G
SOU EXTENSION 1 GRANTED
02/02/2007
EXT1
SOU EXTENSION 1 FILED
02/02/2007
EEXT
SOU TEAS EXTENSION RECEIVED
02/02/2007
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
09/19/2006
PUBO
PUBLISHED FOR OPPOSITION
06/27/2006
NPUB
NOTICE OF PUBLICATION
06/07/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/09/2006
ALIE
ASSIGNED TO LIE
05/05/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/28/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/07/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/24/2006
GNRT
NON-FINAL ACTION E-MAILED
11/16/2005
CNRT
NON-FINAL ACTION WRITTEN
11/16/2005
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/02/2005
DOCK
ASSIGNED TO EXAMINER
09/21/2005
NWAP
NEW APPLICATION ENTERED
08/16/2005
Continuous trademark protection
Get notified about every new filing that threatens LIPOFEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.